EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Increased susceptibility to azithromycin of Pseudomonas aeruginosa biofilms using RPMI 1640 testing media

Adrian Jimenez San San Mauro, Niels Høiby, Oana Ciofu iD

APMIS · 2024

DOI: 10.1111/apm.13413 ↗

Kurz gefasst

Fachartikel in der Zeitschrift APMIS, 2024. Verfasst von Adrian Jimenez San San Mauro und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunology & Microbiology, Costerton Biofilm Center, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Biofilms, Pseudomonas aeruginosa, Azithromycin, Microbial Sensitivity Tests. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Azithromycin (AZM) is efficient for treatment of chronic Pseudomonas aeruginosa biofilm lung infections, despite of resistance in conventional susceptibility testing. It has been shown that planktonic P. aeruginosa are more susceptible to AZM when tested in RPMI 1640 medium. The aim of the study was to test the susceptibility to AZM of P. aeruginosa biofilms in LB vs RPMI 1640 media. We investigated the effect of AZM on planktonic and biofilms of (WT) P. aeruginosa (PAO1), the hypermutable (Δ mutS ) and the antibiotic‐resistant phenotype(Δ nfxB ) mutants. The effect of AZM on young and mature biofilms was investigated in the modified Calgary Biofilm Device by estimation of the minimal biofilm inhibitory concentration (MBIC). The AZM MBIC 90 in LB/RPMI1640 on young biofilms treated for 24 h was 16/4 μg/mL for PAO1, 32/8 μg/mL for Δ mutS, and 256/16 μg/mL for Δ nfxB, while in mature biofilms was 256/2 μg/mL for PAO1 and Δ mutS and 16/1 μg/mL for Δ nfxB. The effect of AZM was improved when the treatment was prolonged to 72 h, supporting the intracellular accumulation of AZM. An increased susceptibility of P. aeruginosa biofilms to AZM was observed in RPMI 1640 than in LB medium. Our results might improve susceptibility testing and dosing of AZM for treatment of biofilm infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsPseudomonas aeruginosaAzithromycinMicrobial Sensitivity TestsAnti-Bacterial AgentsCulture MediaHumansDrug Resistance, Bacterial

Stichwörter der Autor:innen

Pseudomonas aeruginosaRPMI‐1640azithromycinbiofilm

Substanzen

AzithromycinAnti-Bacterial AgentsCulture Media

Autor:innen und Institutionen

  • Institute of Immunology & Microbiology, Costerton Biofilm Center, University of Copenhagen, Copenhagen, Denmark.
  • Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.

ORCID-Profile: Oana Ciofu

Zitieren

APA

San Mauro, A. J. S., Høiby, N., & Ciofu, O. (2024). Increased susceptibility to azithromycin of Pseudomonas aeruginosa biofilms using RPMI 1640 testing media. APMIS. https://doi.org/10.1111/apm.13413

Vancouver

San Mauro AJS, Høiby N, Ciofu O. Increased susceptibility to azithromycin of Pseudomonas aeruginosa biofilms using RPMI 1640 testing media. APMIS. 2024. doi:10.1111/apm.13413

BibTeX
@article{SanMauro2024,
  author = {San Mauro, Adrian Jimenez San and Høiby, Niels and Ciofu, Oana},
  title = {Increased susceptibility to azithromycin of Pseudomonas aeruginosa biofilms using RPMI 1640 testing media},
  journal = {APMIS},
  year = {2024},
  doi = {10.1111/apm.13413}
}
Kostenlos starten →